The DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index.
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Abstract
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic, immunologic, and environmental influences. The incidence of Crohn's disease has steadily increased over the past several decades. The diagnosis and treatment of patients with Crohn's disease has evolved since the last practice guideline was published. These guidelines represent the official practice recommendations of the American College of Gastroenterology and were developed under the auspices of the Practice Parameters Committee for the management of adult patients with Crohn's disease. These guidelines are established for clinical practice with the intent of suggesting preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When exercising clinical judgment, health-care providers should incorporate this guideline along with patient's needs, desires, and their values in order to fully and appropriately care for patients with Crohn's disease. This guideline is intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. To evaluate the level of evidence and strength of recommendations, we used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationSilverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Self-citationSatsangi, J., Silverberg, M. S., Vermeire, S., & Colombel, J.-F. (2006) · Gut · doi:10.1136/gut.2005.082909 · Cited by 3,176
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Self-citationVedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Self-citationLiu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Self-citationColombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Self-citationGomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Self-citationPeyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844
Self-citationPredictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Daperno, M., D'Haens, G., Van Assche, G., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,774
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Levine, A., Griffiths, A., Markowitz, J., Wilson, D. C., Turner, D., Russell, R. K., Fell, J., Ruemmele, F. M., Walters, T., Sherlock, M., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21493 · Cited by 1,512
Van Assche, G., Dignass, A., Panes, J., Beaugerie, L., Karagiannis, J., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,453
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Bloomgren, G., Richman, S., Hotermans, C., Subramanyam, M., Goelz, S., Natarajan, A., Lee, S., Plavina, T., Scanlon, J. V., Sandrock, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107829 · Cited by 1,242
National Cooperative Crohn's Disease Study: Results of drug treatment
Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,239
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Self-citationThe natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
Schwartz, D. A., Loftus, E. V., Tremaine, W. J., Panaccione, R., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32362 · Cited by 1,144
Self-citationFaubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144
Self-citationCertolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.579 · Cited by 1,047
Self-citationMaintenance Therapy with Certolizumab Pegol for Crohn's Disease
Schreiber, S., Khaliq-Kareemi, M., Lawrance, I. C., Thomsen, O. Ø., Hanauer, S. B., McColm, J., Bloomfield, R., & Sandborn, W. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062897 · Cited by 1,043
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
Toruner, M., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., Orenstein, R., Sandborn, W. J., Colombel, J., & Egan, L. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.012 · Cited by 1,017
Self-citationSandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Colombel, J.-F., Panaccione, R., D'Haens, G., Li, J., Rosenfeld, M. R., Kent, J. D., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00159 · Cited by 965
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 933
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Methotrexate for the Treatment of Crohn's Disease
Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 911
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Baert, F., Moortgat, L., Van Assche, G., Caenepeel, P., Vergauwe, P., De Vos, M., Stokkers, P., Hommes, D., Rutgeerts, P., Vermeire, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.056 · Cited by 830
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Thia, K. T., Sandborn, W. J., Harmsen, W. S., Zinsmeister, A. R., & Loftus, E. V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.070 · Cited by 792
Self-citationLichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Price, S., Langholff, W., Londhe, A., & Sandborn, W. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.218 · Cited by 791
Self-citationLaine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., East, J. E., Farraye, F. A., Feagan, B., Ioannidis, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.031 · Cited by 776
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Markowitz, J., Grancher, K., Kohn, N., Lesser, M., & Daum, F. (2000) · Gastroenterology · doi:10.1053/gast.2000.18144 · Cited by 716
Sands, B. E., Feagan, B. G., Rutgeerts, P., Colombel, J.-F., Sandborn, W. J., Sy, R., D’Haens, G., Ben-Horin, S., Xu, J., Rosario, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.008 · Cited by 715
Self-citationFrequency of glucocorticoid resistance and dependency in Crohn's disease.
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V (1994) · Gut · doi:10.1136/gut.35.3.360 · Cited by 654
Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
CANAVAN, C., ABRAMS, K. R., & MAYBERRY, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02854.x · Cited by 622
Crohn's disease management after intestinal resection: a randomised trial
De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 619
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Ford, A. C., Sandborn, W. J., Khan, K. J., Hanauer, S. B., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.73 · Cited by 604
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
Vermeire, S., Noman, M., Van Assche, G., Baert, F., D’Haens, G., & Rutgeerts, P. (2007) · Gut · doi:10.1136/gut.2006.099978 · Cited by 602
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Regueiro, M., Schraut, W., Baidoo, L., Kip, K. E., Sepulveda, A. R., Pesci, M., Harrison, J., & Plevy, S. E. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.051 · Cited by 601
Self-citationEnteral nutritional therapy for induction of remission in Crohn's disease
Zachos, M., Tondeur, M., & Griffiths, A. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub2 · Cited by 598
Travis, S. P. L., Stange, E. F., Lémann, M., Öresland, T., Chowers, Y., Forbes, A., D’Haens, G., Kitis, G., Cortot, A., Prantera, C., et al. (2006) · Gut · doi:10.1136/gut.2005.081950b · Cited by 597
Development of the Crohnʼs disease digestive damage score, the Lémann score
Pariente, B., Cosnes, J., Danese, S., Sandborn, W. J., Lewin, M., Fletcher, J. G., Chowers, Y., DʼHaens, G., Feagan, B. G., Hibi, T., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21506 · Cited by 588
Self-citationPeyrin–Biroulet, L., Deltenre, P., de Suray, N., Branche, J., Sandborn, W. J., & Colombel, J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.014 · Cited by 577
Feuerstein, J. D., Nguyen, G. C., Kupfer, S. S., Falck-Ytter, Y., Singh, S., Gerson, L., Hirano, I., Nguyen, G. C., Rubenstein, J. H., Smalley, W. E., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.032 · Cited by 576
Self-citationSchwartz, D. A., Wiersema, M. J., Dudiak, K. M., Fletcher, J. G., Clain, J. E., Tremaine, W. J., Zinsmeister, A. R., Norton, I. D., Boardman, L. A., Devine, R. M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28676 · Cited by 575
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
A controlled double blind study of azathioprine in the management of Crohn's disease.
Candy, S., Wright, J., Gerber, M., Adams, G., Gerig, M., & Goodman, R. (1995) · Gut · doi:10.1136/gut.37.5.674 · Cited by 567
Oral Budesonide for Active Crohn's Disease
Greenberg, G. R., Feagan, B. G., Martin, F., Sutherland, L. R., Thomson, A., Williams, C. N., Nilsson, L.-G., & Persson, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311303 · Cited by 563
Silva, A. C., Lawder, H. J., Hara, A., Kujak, J., & Pavlicek, W. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.2953 · Cited by 560
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L., Singleton, J., Sessions, J., Hanauer, S., Krawitt, E., Rankin, G., Summers, R., Mekhjian, H., Greenberger, N., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 528
Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease
Rodemann, J. F., Dubberke, E. R., Reske, K. A., Seo, D. H., & Stone, C. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.027 · Cited by 522
Infliximab for the treatment of fistulas in patients with Crohn's disease
Ricart, E., & Sandborn, W. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70414-2 · Cited by 519
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 513
C-Reactive Protein as a Marker for Inflammatory Bowel Disease
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00026 · Cited by 513
Mackey, A. C., Green, L., Liang, L., Dinndorf, P., & Avigan, M. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31802f6424 · Cited by 506
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096316 · Cited by 501
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Self-citationMetronidazole Therapy for Perineal Crohn's Disease: A Follow-Up Study
Brandt, L. J., Bernstein, L. H., Boley, S. J., & Frank, M. S. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80332-6 · Cited by 468
Hanauer, S. B., Korelitz, B. I., Rutgeerts, P., Peppercorn, M. A., Thisted, R. A., Cohen, R. D., & Present, D. H. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.002 · Cited by 460
Feagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
Healing of perineal Crohn's disease with metronidazole
Bernstein, L. H., Frank, M. S., Brandt, L. J., & Boley, S. J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90155-9 · Cited by 440
Vermeire, S., Schreiber, S., Petryka, R., Kuehbacher, T., Hebuterne, X., Roblin, X., Klopocka, M., Goldis, A., Wisniewska-Jarosinska, M., Baranovsky, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32537-5 · Cited by 439
Smoking cessation and the course of Crohn's disease: An intervention study
Cosnes, J., Beaugerie, L., Carbonnel, F., & Gendre, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.23231 · Cited by 431
Rutgeerts, P., van Assche, G., Vermeire, S., D’Haens, G., Baert, F., Noman, M., Aerden, I., de Hertogh, G., Geboes, K., Hiele, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.010 · Cited by 418
Kotlyar, D. S., Lewis, J. D., Beaugerie, L., Tierney, A., Brensinger, C. M., Gisbert, J. P., Loftus, E. V., Peyrin-Biroulet, L., Blonski, W. C., Van Domselaar, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.05.015 · Cited by 414
Self-citationCamma, C., Giunta, M., Rosselli, M., & Cottone, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352848 · Cited by 410
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Chande, N., Patton, P. H., Tsoulis, D. J., Thomas, B. S., & MacDonald, J. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067.pub3 · Cited by 402
A prospective population-based study of triggers of symptomatic flares in IBD
Bernstein, C. N., Singh, S., Graff, L. A., Walker, J. R., Miller, N., & Cheang, M. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.140 · Cited by 400
Dionisio, P. M., Gurudu, S. R., Leighton, J. A., Leontiadis, G. I., Fleischer, D. E., Hara, A. K., Heigh, R. I., Shiff, A. D., & Sharma, V. K. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.713 · Cited by 395
Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 391
Effects of cigarette smoking on the long-term course of Crohn's disease
Cosnes, J., Carbonnel, F., Beaugerie, L., Le Quintrec, Y., & Gendre, J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566589 · Cited by 389
Siddiki, H. A., Fidler, J. L., Fletcher, J. G., Burton, S. S., Huprich, J. E., Hough, D. M., Johnson, C. D., Bruining, D. H., Loftus, E. V., Sandborn, W. J., et al. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.2027 · Cited by 389
Self-citationDiet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation
Sands, B. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.072 · Cited by 373
Self-citationSmall-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial
Solem, C. A., Loftus, E. V., Fletcher, J. G., Baron, T. H., Gostout, C. J., Petersen, B. T., Tremaine, W. J., Egan, L. J., Faubion, W. A., Schroeder, K. W., et al. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.02.017 · Cited by 369
Self-citationAdalimumab for the treatment of fistulas in patients with Crohn’s disease
Colombel, J.-F., Schwartz, D. A., Sandborn, W. J., Kamm, M. A., D’Haens, G., Rutgeerts, P., Enns, R., Panaccione, R., Schreiber, S., Li, J., et al. (2009) · Gut · doi:10.1136/gut.2008.159251 · Cited by 365
Sands, B. E., Blank, M. A., Patel, K., & Van Deventer, S. J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00414-8 · Cited by 359
Self-citationMesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
Singleton, J. W., Hanauer, S. B., Gitnick, G. L., Peppercorn, M. A., Robinson, M. G., Wruble, L. D., & Krawitt, E. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90337-c · Cited by 357
Silverstein, M. D., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Feagan, B. G., Nietert, P. J., Harmsen, W. S., & Zinsmeister, A. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70549-4 · Cited by 354
Self-citationUrsing, B., Alm, T., Bárány, F., Bergelin, I., Ganrot-Norlin, K., Hoevels, J., Huitfeldt, B., Jarnerot, G., Krause, U., Krook, A., et al. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80189-3 · Cited by 352
Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., Plevy, S., Popp, J., Cornillie, F. J., Lukas, M., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.072 · Cited by 339
Self-citationSandborn, W. J., Present, D. H., Isaacs, K. L., Wolf, D. C., Greenberg, E., Hanauer, S. B., Feagan, B. G., Mayer, L., Johnson, T., Galanko, J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00877-1 · Cited by 333
Self-citationA Comparison of Budesonide and Mesalamine for Active Crohn's Disease
Thomsen, O. Ø., Cortot, A., Jewell, D., Wright, J. P., Winter, T., Veloso, F. T., Vatn, M., Persson, T., & Pettersson, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390603 · Cited by 327
Crohn's disease: factors associated with exposure to high levels of diagnostic radiation
Desmond, A. N., O'Regan, K., Curran, C., McWilliams, S., Fitzgerald, T., Maher, M. M., & Shanahan, F. (2008) · Gut · doi:10.1136/gut.2008.151415 · Cited by 324
Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease
Pariente, B., Mary, J.-Y., Danese, S., Chowers, Y., De Cruz, P., D’Haens, G., Loftus, E. V., Louis, E., Panés, J., Schölmerich, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.015 · Cited by 321
Self-citationCONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASE
Willoughby, J. M. T., Beckett, J., Kumar, P., & Dawson, A. M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90268-6 · Cited by 314
Papp, K. A., Gottlieb, A. B., Naldi, L., Pariser, D., Ho, V., Goyal, K., Fakharzadeh, S., Chevrier, M., Calabro, S., Langholff, W., et al. (2015) · PubMed · Cited by 312
120 Crohn's Disease: Factors Associated with Exposure to High Levels of Diagnostic Radiation
Desmond, A. N., O'Regan, K. N., Curran, C., McWilliams, S., Maher, M. M., & Shanahan, F. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)60102-x · Cited by 307
Azathioprine for maintenance of remission in Crohn's disease
Pearson, D., May, G., Fick, G., & Sutherland, L. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067 · Cited by 304
Takeuchi, K., Smale, S., Premchand, P., Maiden, L., Sherwood, R., Thjodleifsson, B., Bjornsson, E., & Bjarnason, I. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00980-8 · Cited by 303
D'Haens, G. R., Vermeire, S., Van Assche, G., Noman, M., Aerden, I., Van Olmen, G., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.010 · Cited by 301
Lochs, H., Mayer, M., Fleig, W. E., Mortensen, P. B., Bauer, P., Genser, D., Petritsch, W., Raithel, M., Hoffmann, R., Gross, V., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70208-3 · Cited by 298
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
Ardizzone, S., Maconi, G., Sampietro, G. M., Russo, A., Radice, E., Colombo, E., Imbesi, V., Molteni, M., Danelli, P. G., Taschieri, A. M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.051 · Cited by 297
Vande Casteele, N., Herfarth, H., Katz, J., Falck-Ytter, Y., & Singh, S. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.031 · Cited by 295
Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study
Felder, J. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01054-6 · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Regueiro, M., & Mardini, H. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200303000-00003 · Cited by 288
Self-citationInfliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03612.x · Cited by 285
Self-citationNguyen, G. C., Loftus, E. V., Hirano, I., Falck-Ytter, Y. T., Singh, S., Sultan, S., Flamm, S. L., Lim, J. K., Rubenstein, J. H., Smalley, W. E., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.038 · Cited by 285
Self-citationMitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., Barclay, M., Begun, J., Bryant, R., Chan, W., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14368 · Cited by 282
Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Leach, S., Gorelik, A., Liew, D., Prideaux, L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.026 · Cited by 280
Sands, B. E., Chen, J., Feagan, B. G., Penney, M., Rees, W. A., Danese, S., Higgins, P. D. R., Newbold, P., Faggioni, R., Patra, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.049 · Cited by 279
Self-citationThia, K. T., Mahadevan, U., Feagan, B. G., Wong, C., Cockeram, A., Bitton, A., Bernstein, C. N., & Sandborn, W. J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20608 · Cited by 278
Hazlewood, G. S., Rezaie, A., Borman, M., Panaccione, R., Ghosh, S., Seow, C. H., Kuenzig, E., Tomlinson, G., Siegel, C. A., Melmed, G. Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.011 · Cited by 276
Louis, E., Michel, V, Hugot, J. P., Reenaers, C., Fontaine, F., Delforge, M., El Yafi, F., Colombel, J. F., & Belaiche, J. (2003) · Gut · doi:10.1136/gut.52.4.552 · Cited by 275
Cleynen, I., González, J. R., Figueroa, C., Franke, A., McGovern, D., Bortlík, M., Crusius, B. J. A., Vecchi, M., Artieda, M., Szczypiorska, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-300777 · Cited by 271
Methotrexate for induction of remission in refractory Crohn's disease
McDonald, J. W., Wang, Y., Tsoulis, D. J., MacDonald, J. K., & Feagan, B. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003459.pub4 · Cited by 270
Cosnes, J., Bourrier, A., Laharie, D., Nahon, S., Bouhnik, Y., Carbonnel, F., Allez, M., Dupas, J., Reimund, J., Savoye, G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.048 · Cited by 268
Allez, M., Lemann, M., Bonnet, J., Cattan, P., Jian, R., & Modigliani, R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05614.x · Cited by 263
Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease
Williet, N., Sandborn, W. J., & Peyrin–Biroulet, L. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.016 · Cited by 260
Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Present, D. H., Sutherland, L. R., Kamm, M. A., Wolf, D. C., Baker, J. P., Hawkey, C., Archambault, A., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24042 · Cited by 257
West, R. L., van der Woude, C. J., Hansen, B. E., Felt‐Bersma, R. J. F., van Tilburg, A. J. P., Drapers, J. A. G., & Kuipers, E. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02247.x · Cited by 256
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
Feagan, B. G., McDonald, J., Rochon, J., Laupacis, A., Fedorak, R. N., Kinnear, D., Saibil, F., Groll, A., Archambault, A., Gillies, R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302602 · Cited by 254
Colombel, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00816-8 · Cited by 254
Evans, J. M., McMahon, A. D., Murray, F. E., McDevitt, D. G., & MacDonald, T. M. (1997) · Gut · doi:10.1136/gut.40.5.619 · Cited by 250
Kappelman, M. D., Farkas, D. K., Long, M. D., Erichsen, R., Sandler, R. S., Sørensen, H. T., & Baron, J. A. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.034 · Cited by 248
Hanauer, S. B., & Strömberg, U. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00122-3 · Cited by 246
Topstad, D. R., Panaccione, R., Heine, J. A., Johnson, D. R. E., MacLean, A. R., & Buie, D. W. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6611-4 · Cited by 244
Frolkis, A. D., Lipton, D. S., Fiest, K. M., Negrón, M. E., Dykeman, J., deBruyn, J., Jette, N., Frolkis, T., Rezaie, A., Seow, C. H., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.297 · Cited by 243
Krieckaert, C. L., Nurmohamed, M. T., & Wolbink, G. J. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201544 · Cited by 242
Subramanian, V., Mannath, J., Ragunath, K., & Hawkey, C. J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04525.x · Cited by 239
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W.-C., Wang, Y., MacDonald, J. K., & Hanauer, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870.pub2 · Cited by 239
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease
Behm, B. W., & Bickston, S. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006893 · Cited by 239
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21417 · Cited by 236
Self-citationGoodhand, J. R., Wahed, M., Mawdsley, J. E., Farmer, A. D., Aziz, Q., & Rampton, D. S. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22916 · Cited by 234
Peyrin-Biroulet, L., Deltenre, P., Ardizzone, S., D'Haens, G., Hanauer, S. B., Herfarth, H., Lémann, M., & Colombel, J.-F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.301 · Cited by 234
Sandborn, W. J., Stenson, W. F., Brynskov, J., Lorenz, R. G., Steidle, G. M., Robbins, J. L., Kent, J. D., & Bloom, B. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.002 · Cited by 231
Corticosteroids for maintenance of remission in Crohn's disease
Steinhart, A. H., Ewe, K., Griffiths, A. M., Modigliani, R., & Thomsen, O. O. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000301 · Cited by 224
Geboes, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00044-0 · Cited by 223
Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
Ford, A. C., Kane, S. V., Khan, K. J., Achkar, J.-P., Talley, N. J., Marshall, J. K., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.71 · Cited by 223
Henriksen, M., Jahnsen, J., Lygren, I., Aadland, E., Schulz, T., Vatn, M. H., Moum, B., & THE IBSEN STUDY GROUP (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520601076124 · Cited by 222
Metronidazole therapy for Crohn's disease and associated fistulae.
Jakobovits, J., & Schuster, M. M. (1984) · PubMed · Cited by 220
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
Steinhart, A. H., Feagan, B. G., Wong, C. J., Vandervoort, M., Mikolainis, S., Croitoru, K., Seidman, E., Leddin, D. J., Bitton, A., Drouin, E., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34225 · Cited by 216
Guellouz, S., Pariente, B., Benet, C., Baudry, C., Lourenco, N., Kraemer, A., Allez, M., & Gornet, J.-M. (2014) · Case Reports in Gastroenterology · doi:10.1159/000360844 · Cited by 216
CAPRILLI, R., ANDREOLI, A., CAPURSO, L., CORRAO, G., ALBASIO, G. D., GIOIENI, A., ASSUERO LANFRANCHI, G., PALADINI, I., PALLONE, F., PONTI, V., et al. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00158.x · Cited by 213
Clinical experience with infliximab therapy in 100 patients with Crohn's disease
Farrell, R. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02159-6 · Cited by 209
Löfberg, R., Rutgeerts, P., Malchow, H., Lamers, C., Danielsson, A., Olaison, G., Jewell, D., Ostergaard Thomsen, O., Lorenz-Meyer, H., Goebell, H., et al. (1996) · Gut · doi:10.1136/gut.39.1.82 · Cited by 209
Samuel, S., Bruining, D. H., Loftus, E. V., Becker, B., Fletcher, J. G., Mandrekar, J. N., Zinsmeister, A. R., & Sandborn, W. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.03.026 · Cited by 206
Self-citationMesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease
Brignola, C., Cottone, M., Pera, A., Ardizzone, S., Scribano, M. L., de Franchis, R., D'Arienzo, A., D'Albasio, G., & Pennestri, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90059-4 · Cited by 206
A controlled trial of azathioprine in Crohn's disease
Rosenberg, J. L., Levin, B., Wall, A. J., & Kirsner, J. B. (1975) · The American Journal of Digestive Diseases · doi:10.1007/bf01070829 · Cited by 201
Neurath, M. F., Wanitschke, R., Peters, M., Krummenauer, F., zum Büschenfelde, K.-H. M., & Schlaak, J. F. (1999) · Gut · doi:10.1136/gut.44.5.625 · Cited by 199
Interventions for prevention of post-operative recurrence of Crohn's disease
Doherty, G., Bennett, G., Patil, S., Cheifetz, A., & Moss, A. C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006873.pub2 · Cited by 197
Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis
Laukoetter, M. G., Mennigen, R., Hannig, C. M., Osada, N., Rijcken, E., Vowinkel, T., Krieglstein, C. F., Senninger, N., Anthoni, C., & Bruewer, M. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1402-9 · Cited by 196
LICHTENSTEIN, G. R., DIAMOND, R. H., WAGNER, C. L., FASANMADE, A. A., OLSON, A. D., MARANO, C. W., JOHANNS, J., LANG, Y., & SANDBORN, W. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04027.x · Cited by 195
Self-citationPostoperative recurrent luminal Crohnʼs Disease: A systematic review
De Cruz, P., Kamm, M. A., Prideaux, L., Allen, P. B., & Desmond, P. V. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21825 · Cited by 192
Systematic review with meta‐analysis: faecal diversion for management of perianal Crohn's disease
Singh, S., Ding, N. S., Mathis, K. L., Dulai, P. S., Farrell, A. M., Pemberton, J. H., Hart, A. L., Sandborn, W. J., & Loftus, E. V. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13356 · Cited by 191
Self-citationTraditional corticosteroids for induction of remission in Crohn's disease
Benchimol, E. I., Seow, C. H., Steinhart, A. H., & Griffiths, A. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006792.pub2 · Cited by 182
Do NSAIDs, Antibiotics, Infections, or Stress Trigger Flares in IBD?
Singh, S., Graff, L. A., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.15 · Cited by 181
Preliminary Study of Ciprofloxacin in Active Crohn's Disease
Arnold, G. L., Beaves, M. R., Pryjdun, V. O., & Mook, W. J. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200201000-00002 · Cited by 181
Ferrante, M., Colombel, J., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G. R., van der Woude, C. J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.010 · Cited by 179
Reinisch, W., Wang, Y., Oddens, B. J., & Link, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04987.x · Cited by 179
Prantera, C., Lochs, H., Grimaldi, M., Danese, S., Scribano, M. L., & Gionchetti, P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.032 · Cited by 176
Reinisch, W., Angelberger, S., Petritsch, W., Shonova, O., Lukas, M., Bar-Meir, S., Teml, A., Schaeffeler, E., Schwab, M., Dilger, K., et al. (2010) · Gut · doi:10.1136/gut.2009.194159 · Cited by 172
Fistulating Anal Crohn's Disease: Results of Combined Surgical and Infliximab Treatment
Hyder, S. A., Travis, S. P. L., Jewell, D. P., McC. Mortensen, N. J., & George, B. D. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0656-5 · Cited by 171
Narrow Band Imaging for Detection of Dysplasia in Colitis: A Randomized Controlled Trial
Ignjatovic, A., East, J. E., Subramanian, V., Suzuki, N., Guenther, T., Palmer, N., Bassett, P., Ragunath, K., & Saunders, B. P. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.67 · Cited by 170
Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-311892 · Cited by 169
Dubinsky, M. C., Reyes, E., Ofman, J., Chiou, C.-F., Wade, S., & Sandborn, W. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41900.x · Cited by 167
Pellisé, M., López-Cerón, M., Rodríguez de Miguel, C., Jimeno, M., Zabalza, M., Ricart, E., Aceituno, M., Fernández-Esparrach, G., Ginès, A., Sendino, O., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.05.013 · Cited by 166
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Torres, J., Caprioli, F., Katsanos, K. H., Lobatón, T., Micić, D., Zerôncio, M., Assche, G. V., Lee, J. C., Lindsay, J. O., Rubin, D. T., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw116 · Cited by 162
Yarur, A. J., Kubiliun, M. J., Czul, F., Sussman, D. A., Quintero, M. A., Jain, A., Drake, K. A., Hauenstein, S. I., Lockton, S., Deshpande, A. R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.12.026 · Cited by 161
Budesonide for maintenance of remission in Crohn's disease
Kuenzig, M. E., Rezaie, A., Seow, C. H., Otley, A. R., Steinhart, A. H., Griffiths, A. M., Kaplan, G. G., & Benchimol, E. I. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002913.pub3 · Cited by 160
Enteral nutrition for maintenance of remission in Crohn's disease
Akobeng, A. K., & Thomas, A. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005984.pub2 · Cited by 160
Gervais, D. A., Hahn, P. F., O’Neill, M. J., & Mueller, P. R. (2002) · Radiology · doi:10.1148/radiol.2223010554 · Cited by 159
Corticosteroids in Crohn's disease
Yang, Y., & Lichtenstein, G. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05596.x · Cited by 158
Self-citationTreating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
Sandborn, W. J., Hanauer, S., Van Assche, G., Panés, J., Wilson, S., Petersson, J., & Panaccione, R. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.02.021 · Cited by 158
Targownik, L. E., Sexton, K. A., Bernstein, M. T., Beatie, B., Sargent, M., Walker, J. R., & Graff, L. A. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.147 · Cited by 157
Yoshida, K., Fukunaga, K., Ikeuchi, H., Kamikozuru, K., Hida, N., Ohda, Y., Yokoyama, Y., Iimuro, M., Takeda, N., Kato, K., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21928 · Cited by 156
Meta‐analysis: mortality in Crohn’s disease
Canavan, C., Abrams, K. R., & Mayberry, J. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03276.x · Cited by 156
Antibody markers in the diagnosis of inflammatory bowel disease
Mitsuyama, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1304 · Cited by 155
Sandborn, W. J., Feagan, B. G., Radford‐Smith, G. L., Kovacs, A., Enns, R., Innes, A., & Patel, J. (2004) · Gut · doi:10.1136/gut.2003.035253 · Cited by 154
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
Sorrentino, D. R., Paviotti, A., Terrosu, G., Avellini, C., Geraci, M., & Zarifi, D. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.01.016 · Cited by 154
European trial of cyclosporine in chronic active Crohn's disease: A 12-month study
Stange, E. F., Modigliani, R., Peña, A. S., Wood, A. J., Feutren, G., & Smith, P. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90384-4 · Cited by 152
Gendre, J., Mary, J., Florent, C., Modigliani, R., Colombel, J., Soulé, J., Galmiche, J., Lerebours, É., Descos, L., Viteau, J. M., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90411-5 · Cited by 150
Modigliani, R., Colombel, J. F., Jl, D., Dapoigny, M. C., Costil, V., Veyrac, M., Duclos, B., Soulé, J. C., Jp, G., Jp, G., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608877 · Cited by 149
Rutgeerts, P., Onette, E., Vantrappen, G., Geboes, K. J., Broeckaert, L., & Talloen, L. (1980) · Endoscopy · doi:10.1055/s-2007-1021762 · Cited by 149
Iacucci, M., Kaplan, G. G., Panaccione, R., Akinola, O., Lethebe, B. C., Lowerison, M. W., Leung, Y., Novak, K. L., Seow, C. H., Urbanski, S. J., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.417 · Cited by 149
Natalizumab for induction of remission in Crohn's disease
MacDonald, J. K., & McDonald, J. W. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006097.pub2 · Cited by 148
Annunziata, M. L., Caviglia, R., Papparella, L. G., & Cicala, M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2072-0 · Cited by 147
Methotrexate in Crohn's Disease: Long-Term Efficacy and Toxicity
Lémann, M., Zenjari, T., Bouhnik, Y., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02190.x · Cited by 147
Regueiro, M. D., Velayos, F. S., Greer, J. B., Bougatsos, C., Chou, R., Sultan, S., & Singh, S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.039 · Cited by 147
Self-citationCombination of Ciprofloxacin and Metronidazole in Severe Perianal Crohn’s Disease
Solomon, M. J., McLeod, R., O'Connor, B., et al. (1993) · Canadian Journal of Gastroenterology · doi:10.1155/1993/610272 · Cited by 146
Deepak, P., Fletcher, J. G., Fidler, J. L., Barlow, J. M., Sheedy, S. P., Kolbe, A. B., Harmsen, W. S., Loftus, E. V., Hansel, S. L., Becker, B. D., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.177 · Cited by 145
Self-citation
Cited by
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz180 · Cited by 1,374
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Adamina, M., Bonovas, S., Raine, T., Spinelli, A., Warusavitarne, J., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz187 · Cited by 1,106
The microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P., & Quigley, E. M. M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.003 · Cited by 837
Evidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.24025 · Cited by 693
Metadata
- Authors
- Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E.
- Venue
- American Journal of Gastroenterology
- Published
- 2018-04
- Volume
- 113
- Issue
- 4
- Pages
- 481-517
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2794595980
- Cited by
- 1,421
- References
- 312
- FWCI
- 75.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.